{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:46:19Z","timestamp":1784133979706,"version":"3.55.0"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":11024,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1983,1]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The objective was to determine whether deltoid as compared to gluteal injection of morphine and methadone produce differential plasma levels and analgesic effects. Thirty\u2010two postoperative cancer patients received deltoid and gluteal injections of morphine, 8 and 16 mg, within a double\u2010blind, twin crossover design. Forty\u2010four patients received deltoid or gluteal methadone, 10 mg. Deltoid morphine resulted in peak plasma levels 1.8 times (<jats:italic>P<\/jats:italic> &lt; 0.05) those observed following gluteal morphine. Deltoid methadone resulted in peak levels 2.5 times (<jats:italic>P<\/jats:italic> &lt; 0.005) those following gluteal injection. Deltoid morphine resulted in an area under the drug level\u2014time (0 to 4 hours) curve 1.4 times (N.S.) the area observed following gluteal injection. Deltoid methadone resulted in an area under the drug level\u2014time (0 to 4 hours) curve 2.2 times (<jats:italic>P<\/jats:italic> &lt; 0.001) the area observed following gluteal injection. Deltoid methadone, but not morphine, provided greater (1.7\u2010fold, <jats:italic>P<\/jats:italic> &lt; 0.05) pain relief than gluteal injection. If more rapid and enhanced analgesia is indicated, then the deltoid site may be preferable over the gluteal site for standard doses of methadone and other lipid soluble analgesics. In addition, the relative potency of compounds of widely differing lipid solubility may depend upon the site of intramuscular injection.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1983.tb02704.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:53:39Z","timestamp":1362790419000},"page":"48-55","source":"Crossref","is-referenced-by-count":44,"title":["Plasma Levels and Analgesia Following Deltoid and Gluteal Injections of Methadone and Morphine"],"prefix":"10.1002","volume":"23","author":[{"given":"PATRICIA Y.","family":"GRABINSKI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT F.","family":"KAIKO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADA G.","family":"ROGERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAYMOND W.","family":"HOUDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cpt197517144","article-title":"Blood flow in muscle groups and drug absorption","volume":"17","author":"Evans EF","year":"1974","journal-title":"Clin Pharmacol Therap."},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0773.1969.tb03069.x","volume-title":"Absorption of Injected Insulin.","author":"Binder C.","year":"1969"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(72)90442-0"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975182215"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196012163"},{"key":"e_1_2_1_7_2","first-page":"127","volume-title":"Methods in Narcotic Research.","author":"Wallenstein SL","year":"1975"},{"key":"e_1_2_1_8_2","article-title":"Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid","author":"Grabinski PY","journal-title":"J Pharm Sci."},{"key":"e_1_2_1_9_2","first-page":"201","article-title":"Urinary excretion of morphine and its metabolites in morphine dependent subjects","volume":"192","author":"Yeh SY","year":"1975","journal-title":"J Pharmacol Exp Therap."},{"key":"e_1_2_1_10_2","first-page":"253","article-title":"Quantitative determination of morphine in serum by radioimmunoassay","volume":"178","author":"Spector SJ","year":"1971","journal-title":"J Pharmacol Exp Therap."},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.174.4007.421"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)92558-5"},{"key":"e_1_2_1_13_2","first-page":"265","volume-title":"Statistical Method in Biological Assay","author":"Finney DJ","year":"1964"},{"key":"e_1_2_1_14_2","first-page":"433","article-title":"Measurement of the pKa's partition and drug distribution coefficient of narcotics and narcotic antagonists, their pH and temperature dependence, and their significance in clinical practice","author":"Kaufman JJ","year":"1975","journal-title":"Proceedings of The Committee on Problems of Drug Depencence."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.1.10"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975182180"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(81)90324-9"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1972136923"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977212147"},{"key":"e_1_2_1_20_2","first-page":"457","article-title":"Important clinical pharmacologic considerations in the use of methadone in cancer patients","volume":"63","author":"Ettinger DS","year":"1970","journal-title":"Cancer Treat Rep."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198103000-00003"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975176629"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976196752"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197824152"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979263354"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.214"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(81)80005-4"},{"key":"e_1_2_1_28_2","unstructured":"InturrisiCEPersonal communication."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1983.tb02704.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1983.tb02704.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:47:51Z","timestamp":1697788071000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1983.tb02704.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,1]]}},"alternative-id":["10.1002\/j.1552-4604.1983.tb02704.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1983.tb02704.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,1]]}}}